Data for: A cost analysis of non-invasive blood-based microRNA testing versus CT scans for follow-up in patients with testicular germ cell tumors

Published: 31-03-2020| Version 1 | DOI: 10.17632/5463ybs3jw.1
Matthew Murray


A Markov model to explore cost savings from implementing serum microRNA testing in place of CT scans for testicular germ cell tumor follow-up